Literature DB >> 17387612

Musculoskeletal complaints and serum autoantibodies associated with chronic hepatitis C and nonalcoholic fatty liver disease.

Sharon E Banks1, Thomas R Riley, Stanley J Naides.   

Abstract

We sought to compare the musculoskeletal symptoms and immune markers found in chronic hepatitis C (HCV) and nonalcoholic fatty liver disease (NAFLD). Patients with HCV or NAFLD answered a questionnaire and donated serum for autoantibody testing. Univariate analysis between the HCV and NAFLD groups revealed joint pain in 67% of the HCV group and 65% of the NAFLD group. Those with joint pain reported inflammatory characteristics that were similar between the groups. The presence of a positive rheumatoid factor and cryoglobulins was higher in the HCV group, however both groups had a similar prevalence of a low positive antinuclear antibody (ANA). We conclude that the NAFLD group reported a higher amount of joint pain and inflammatory joint symptoms than anticipated. We were unable to determine a variable that predicted the presence of joint pain. Therefore, more investigation is needed to determine whether these findings are due to liver disease alone.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17387612     DOI: 10.1007/s10620-006-9109-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  16 in total

Review 1.  Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapies.

Authors:  Dimitrios Vassilopoulos; Leonard H Calabrese
Journal:  Arthritis Rheum       Date:  2002-03

Review 2.  Cytokine production in the rheumatoid joint: implications for treatment.

Authors:  M Feldmann; F M Brennan; D Chantry; C Haworth; M Turner; E Abney; G Buchan; K Barrett; D Barkley; A Chu
Journal:  Ann Rheum Dis       Date:  1990-06       Impact factor: 19.103

Review 3.  Preventive care in chronic liver disease.

Authors:  T R Riley; J P Smith
Journal:  J Gen Intern Med       Date:  1999-11       Impact factor: 5.128

4.  Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients.

Authors:  J Crespo; A Cayón; P Fernández-Gil; M Hernández-Guerra; M Mayorga; A Domínguez-Díez; J C Fernández-Escalante; F Pons-Romero
Journal:  Hepatology       Date:  2001-12       Impact factor: 17.425

5.  Musculoskeletal pain and fatigue are associated with chronic hepatitis C: a report of 239 hepatology clinic patients.

Authors:  A Barkhuizen; H R Rosen; S Wolf; K Flora; K Benner; R M Bennett
Journal:  Am J Gastroenterol       Date:  1999-05       Impact factor: 10.864

6.  Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease.

Authors:  Luca Valenti; Anna Ludovica Fracanzani; Paola Dongiovanni; Gennaro Santorelli; Adriana Branchi; Emanuela Taioli; Gemino Fiorelli; Silvia Fargion
Journal:  Gastroenterology       Date:  2002-02       Impact factor: 22.682

7.  Arthritis in patients with chronic hepatitis C virus infection.

Authors:  J Rivera; A García-Monforte; A Pineda; J Millán Núñez-Cortés
Journal:  J Rheumatol       Date:  1999-02       Impact factor: 4.666

8.  Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients.

Authors:  D Buskila; A Shnaider; L Neumann; M Lorber; D Zilberman; N Hilzenrat; O J Kuperman; E Sikuler
Journal:  Semin Arthritis Rheum       Date:  1998-10       Impact factor: 5.532

Review 9.  Advances in the understanding and treatment of nonalcoholic fatty liver disease.

Authors:  Stephen A Harrison; Adrian M Di Bisceglie
Journal:  Drugs       Date:  2003       Impact factor: 9.546

10.  Nonalcoholic steatohepatitis: an expanded clinical entity.

Authors:  B R Bacon; M J Farahvash; C G Janney; B A Neuschwander-Tetri
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

View more
  4 in total

Review 1.  Useful biomarkers for assessment of hepatitis C virus infection-associated autoimmune disorders.

Authors:  Deng-Ho Yang; Ling-Jun Ho; Jenn-Haung Lai
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

2.  Predictors of pain intensity and pain functioning in patients with the hepatitis C virus.

Authors:  Benjamin J Morasco; Marilyn Huckans; Jennifer M Loftis; Jonathan Woodhouse; Adriana Seelye; Dennis C Turk; Peter Hauser
Journal:  Gen Hosp Psychiatry       Date:  2010-04-27       Impact factor: 3.238

3.  Prevalence and risk factors for patient-reported joint pain among patients with HIV/hepatitis C coinfection, hepatitis C monoinfection, and HIV monoinfection.

Authors:  Alexis Ogdie; Wyki Gina Pang; Kimberly A Forde; Bhangle D Samir; Lakeisha Mulugeta; Kyong-Mi Chang; David E Kaplan; Valerianna K Amorosa; Jay R Kostman; Rajender K Reddy; Ralph H Schumacher; Vincent Lo Re
Journal:  BMC Musculoskelet Disord       Date:  2015-04-19       Impact factor: 2.362

Review 4.  Prevalence and Significance of Antinuclear Antibodies in Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Authors:  Ling Luo; Qianqian Ma; Limin Lin; Hao Wang; Junzhao Ye; Bihui Zhong
Journal:  Dis Markers       Date:  2022-08-12       Impact factor: 3.464

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.